biotechnology companies

biotechnology companies

Biotech Catches Eye of Bill Gates

allthingsd.com
For chief executives of startup biotechnology companies, traveling hat-in-hand to investor conferences in pursuit of new financing is an unrelenting task. So it was a particularly good day for Michael Pellini, CEO of Foundation Medicine Inc., when an unsolicited query from Bill Gates popped up in his inbox last September....
Biotech Catches Eye of Bill Gates

An Angry AOL Shareholder Thinks Tim Armstrong Is Doing A Terrible Job, And These People Should Be On The Board (AOL)

www.businessinsider.com
Starboard Value LP owns a big stake in AOL, and it thinks CEO Tim Armstrong could be doing a better job. It's declared a proxy war, today announcing four people it thinks should be elected to Yahoo's board.  They are: Ronald S. Epstein is the Founder and CEO of Epicenter...
An Angry AOL Shareholder Thinks Tim Armstrong Is Doing A Terrible Job, And These People Should Be On The Board (AOL)
Map: Here's where tech jobs are hot in the U.S.

Court to Reconsider Gene Patents

allthingsd.com
A federal appeals court on Friday will reconsider whether isolated human genes can be patented, in a case that could reshape how biotechnology companies develop sophisticated screening tests and treatments for cancer and other diseases. The hearing marks the latest legal twist in the fight over a series of Myriad...
Court to Reconsider Gene Patents
The JOBS Act: Support Growing Biotech Companies Developing Breakthrough Medicines

Profit and PR are the real enemies of innovation | Peter Wilby

www.guardian.co.uk
From drugs to computers, the big rewards are now in tweaking existing products and presenting them as ground-breakingFor more than a decade, we have been told that the pharmaceutical industry faces a crisis: it finds it more and more difficult to develop new drugs. The returns on research and development,...
Profit and PR are the real enemies of innovation | Peter Wilby

Biotech Has a Rare, $516 Million Moment of Brightness

allthingsd.com
The announcement by Third Rock Ventures today that it has raised $516 million to create about 15 new biotechnology companies over the next few years marks a bright moment amid the tough climate for life sciences startups. The bottom fell out for young biotechs after the economic downturn. Last year...
Biotech Has a Rare, $516 Million Moment of Brightness

Biotech IPOs Sizzle Amid R&D Successes

online.wsj.com
Biotechnology companies are enjoying their best run with initial public offerings in a decade, amid an upswing in new drug approvals, strong performance by some already public biotech firms and legal changes....
Biotech IPOs Sizzle Amid R&D Successes
× Just a test of the new info bar. What do you think?